Comparison of the efficacy between DEB(drug-eluting-bead)-TACE and hepasphere with the use of epirubicin :a randomized prospective phase 2 trial
Phase 2
Recruiting
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000013966
- Lead Sponsor
- kurume university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
patients with extrahepatic and metastasis of the lymph node macroscopic vascular invasion active serious infection exept for hepatic B or C infection active cancer Pregnant or lacting women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method Time to local progression MST TE mRESICT